FindTrial
Sign In

Comparison of Clinical Outcomes After Total Hip Arthroplasty Using Different Approaches: A Randomized Controlled Clinical Trial

Comparison of Clinical Outcomes After Total Hip Arthroplasty Using Different Approaches: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020770
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthritis, osteonecrosis of the femoral head, developmental dysplasia of the hip

Interventions

DAA group:direct anterior approach (DAA)
PLA group:posterolateral approach (PLA)

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of hip osteoarthritis, femoral head necrosis or developmental dysplasia of the hip (Crowe I-II).

Exclusion criteria

Exclusion criteria: 1. Diagnosis of developmental dysplasia of the hip (Crowe III-IV); 2. Anemia (male Hb 30 kg/m2; 6. Obvious osteoporosis; 7. history of hip surgery or infection before; Other reasons not fit for this study.

Design outcomes

Primary

MeasureTime frame
Hemoglobin (Hb);—

Secondary

MeasureTime frame
Hip function score (Harris hip score, VAS score);—

Countries

China

Contacts

Public ContactQirong Qian

Shanghai Changzheng Hospital

qianqr@163.com+86 13818940205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026